Fosamax Warning Renewed

by Patrick Malone & Associates P.C. | DC Injury Lawyers

Drugs known as bisphosphonates are huge sellers in the U.S., prescribed mostly for post-menopausal women to protect against bone fractures. The risk of osteoporosis (bone density loss) increases after menopause.

But the possible side effects of bisphosphonates have long been of concern if they’re taken for an extended period. Bisphosphonates have a long half-life, which means they can remain active in the body for years, and over time, users might experience cumulative damage.

In its column “Ask the Pharmacist,” Consumer Reports has renewed concern about bisphosphonates (Fosamax, Boniva, Actonel), and advises women with low bone density not severe enough to qualify as osteoporosis to forgo them. The benefits, CR says, do not appear to outweigh the risk sudden femur fractures and decay of the jaw bone.

We wrote about bone-building drugs a couple of years ago in the wake of lawsuits over the death of jaw bone tissue associated with the use of Fosamax, the most well-known bisphosphonate. Sometimes this adverse event requires surgery to remove parts of the jaw.

Another risk of this class of drugs is sudden femur (thigh bone) fractures that can happen during activity as simple as taking a step. Other unpleasant side effects include gastrointestinal ulcers, eye inflammation and incapacitating muscle, bone and joint pain.

Even the diagnosis of osteopenia—lowered bone mineral density that’s often a precursor to osteoporosis—does not warrant taking these drugs. CR supports its stance with recent analysis from the federal Agency for Healthcare Research and Quality (AHRQ).

In 2010, the FDA required Merck, the manufacturer of Fosamax, to issue new warnings about the risk of femur fractures. In June, as noted on, the FDA released new guidelines for taking bisphosphonates. They indicated that even people with osteoporosis should limit their exposure to bisphosphonates. The feds recommended, per an FDA report from 2011, that use be limited from three to five years, at least until more definitive data become available.

The 2011 report, according to AboutLawsuits, was issued before an FDA advisory committee was convened to review the risks associated with the long-term use of the medications. The panel favored stronger bone-fracture warning labels but did not finalize length-of-use recommendations.

Merck still faces hundreds of Fosamax fracture lawsuits.

To reduce your likelihood of brittle bones, according to Consumer Reports:

  • Eat calcium-rich foods such as green leafy vegetables, low-fat dairy products, shellfish, canned sardines and salmon, and take supplements as directed by your doctor to ensure you're getting at least 1,200 milligrams of calcium per day.
  • Check your vitamin D blood level. It should be greater than 30 nanograms per milliliter; supplement your diet as directed by your doctor.
  • Spend 30 minutes or more each day doing weight-bearing exercises such as walking and weightlifting to support bones and increase muscle strength.
  • Do a safety check of your home, which is where most falls occur.
  • Learn tai chi or similar exercises to improve balance, and use a cane if necessary.
  • Limit alcohol consumption and sleeping pills.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patrick Malone & Associates P.C. | DC Injury Lawyers | Attorney Advertising

Written by:

Patrick Malone & Associates P.C. | DC Injury Lawyers

Patrick Malone & Associates P.C. | DC Injury Lawyers on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.